跳至主要内容
临床试验/NCT02372903
NCT02372903已完成不适用

Pilot Study About Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Laparoscopic Diagnosis of Endometriosis

University of Cagliari1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Change of Pelvic pain as measured by visual analogue scale

研究概览

简要总结

One of the main symptoms of endometriosis is pain, but his pathogenesis is not fully understood. The detection of mast cells in the endometriosis lesions supports the hypothesis that mast cell degranulation may contribute to development of pain and hyperalgesia.

N-acylethanolamines (NAEs) are a class of endogenous compounds that regulate inflammation and pain, controlling mast-cell activation. The aim of the study is to investigate the efficacy of palmitoylethanolamide-polydatin combination on pain relief in symptomatic patients with endometriosis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • age between 18 and 50 years;
  • pain visual analog scale (VAS) score>4
  • laparoscopic diagnosis of endometriosis (performed in the last three years),
  • no assumption of any drugs (in particularly estro-progestinic, progestinic, gonadotropin-releasing hormone (GnRH) agonists and antagonists)
  • persistence of symptoms by at least one month

排除标准

  • presence of other associated diseases
  • assumption of drugs
  • menopause
  • pregnancy
  • unable or unwilling to give written consent patients
  • adverse reaction or hypersensitivity to active substance or excipients

研究组 & 干预措施

Endometriosis

Experimental

Symptomatic patients with laparoscopic diagnosis of endometriosis

干预措施: Administration of micronized Palmitoylethanolamide (PEA)- Transpolydatin (Drug)

结局指标

主要结局

Change of Pelvic pain as measured by visual analogue scale

时间窗: Change from Baseline Pelvic Pain at 90 days of treatment

次要结局

  • Change of Pelvic pain as measured by visual analogue scale(Change from baseline Pelvic Pain after 30 days from the suspension of the therapy)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stefano Angioni

Associate Professor

University of Cagliari

研究点 (1)

Loading locations...

相似试验